ADIA OTC
Adia Med Inc.
1W: -10.7%
1M: -22.8%
3M: -29.8%
YTD: +54.5%
1Y: +145.7%
3Y: +440.5%
5Y: +620.7%
$0.11
-0.03 (-22.79%)
Weekly Expected Move ±20.0%
$0
$0
$0
$0
$0
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Supply Chain
Smart Money Score
No convergence signal
Key Statistics
Market Cap$10.2M
52W Range0.025-0.278
Volume92,465
Avg Volume19,441
Beta-8.23
Dividend—
Analyst Ratings
No analyst coverage
Company Info
CEOLarry Powalisz
Employees3
SectorHealthcare
IndustryMedical - Pharmaceuticals
IPO Date2012-04-11
Websiteadiamed.com
1561 West Fairbanks Avenue
Winter Park, FL 32789
US
Winter Park, FL 32789
US
831-241-4900
About Adia Med Inc.
Adia Med Inc. is a publicly traded company dedicated to advancing regenerative medicine and healthcare innovation. The company operates through its primary divisions: Adia Med clinics and Adia Labs LLC. Adia Med clinics deliver specialized regenerative treatments, including stem cell therapies, while Adia Labs manufactures and distributes regenerative products. The company is also involved in multiple Institutional Review Board (IRB)-approved clinical studies.
Latest News
Adia Nutrition, Inc. GAAP EPS of $0.00
Adia Med of Winter Park Expands into Cosmetics Due to High Patient Demand - Now Interviewing Nurse Practitioners for Hair Growth and Aesthetic Procedures
Adia Nutrition Announces Subsidiary Adia Med's Submission of Second Clinical Study for IRB Review Targeting Lower Back Pain with AdiaVita
Adia Nutrition Inc. Plans to Initiate Four to Five New Clinical Studies in 2026, Including Expansions in Autism and New Rheumatoid Arthritis Research
Adia Nutrition Inc. Announces Effectiveness of Form 10 Registration Statement - Now a Fully Reporting SEC Company and Advancing Toward Next Phase of Growth and NASDAQ Uplisting
Recent Insider Trades
No insider trades found